Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | peptide deformylase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) | 0.0279 | 0.7552 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0061 | 0 | 0.5 |
Giardia lamblia | DNA repair protein RAD52 | 0.0349 | 1 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0266 | 0.7092 | 0.9392 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0061 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) | 0.0279 | 0.7552 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0061 | 0 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0099 | 0.1331 | 0.016 |
Plasmodium vivax | peptide deformylase, putative | 0.0279 | 0.7552 | 0.5 |
Plasmodium falciparum | peptide deformylase | 0.0279 | 0.7552 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0106 | 0.1573 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Chlamydia trachomatis | peptide deformylase | 0.0279 | 0.7552 | 0.5 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0143 | 0.286 | 0.3787 |
Entamoeba histolytica | Rad52/22 family double-strand break repair protein, putative | 0.0099 | 0.1331 | 0.016 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0143 | 0.286 | 0.3787 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0106 | 0.1573 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0106 | 0.1573 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0294 | 0.807 | 1 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.7809 |
Toxoplasma gondii | hypothetical protein | 0.0279 | 0.7552 | 1 |
Trypanosoma brucei | Polypeptide deformylase 1 | 0.0106 | 0.1573 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0061 | 0 | 0.5 |
Trypanosoma brucei | Peptide deformylase 2 | 0.0106 | 0.1573 | 0.5 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0106 | 0.1573 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Mycobacterium ulcerans | peptide deformylase | 0.0279 | 0.7552 | 1 |
Leishmania major | polypeptide deformylase-like protein, putative | 0.0106 | 0.1573 | 1 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.7809 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | peptide deformylase | 0.0279 | 0.7552 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.119 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.098 uM | Inhibition of the isolated native E. coli peptide deformylase (PDF) | ChEMBL. | 11384231 |
IC50 (binding) | = 0.098 uM | Inhibition of the isolated native E. coli peptide deformylase (PDF) | ChEMBL. | 11384231 |
MIC (functional) | = 4 ug ml-1 | In vitro antibacterial activity against Moraxella catarrhalis RA21 | ChEMBL. | 11384231 |
MIC (functional) | = 32 ug ml-1 | In vitro antibacterial activity against Escherichia coli | ChEMBL. | 11384231 |
MIC (functional) | = 32 ug ml-1 | In vitro antibacterial activity against Escherichia coli | ChEMBL. | 11384231 |
MIC (functional) | > 64 ug ml-1 | In vitro antibacterial activity against Haemophilus influenzae 11 | ChEMBL. | 11384231 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.